Harry Heijerman
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Cystic Fibrosis Research Advances
- Inhalation and Respiratory Drug Delivery
- Neonatal Respiratory Health Research
- Tracheal and airway disorders
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cystic Fibrosis Research Advances 106
- Inhalation and Respiratory Drug Delivery 17
- Neonatal Respiratory Health Research 17
- Tracheal and airway disorders 13
- Epidemiology 18
- Pneumonia and Respiratory Infections 12
- Co-authors
- Daan J. Touw (32 shared papers)Gerd Döring (4 shared papers)J.S. Elborn (4 shared papers)Steven Conway (4 shared papers)Henderik W. Frijlink (10 shared papers)Elsbeth M. Westerman (7 shared papers)Patrick A. Flume (1 shared paper)P.P.H. Le Brun (11 shared papers)
- Journals
- Journal of Cystic Fibrosis (49 papers)Therapeutic Drug Monitoring (8 papers)Pediatric Pulmonology (6 papers)Respiratory Medicine (4 papers)Journal of Personalized Medicine (4 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Harry Heijerman
142 papers receiving 5.1k citations
Harry Heijerman's Hit Papers
Peers
Comparison fields: 5 of 144
- Pulmonary and Respiratory Medicine 3.6k
- Molecular Medicine 442
- Critical Care and Intensive Care Medicine 158
- Otorhinolaryngology 126
- Internal Medicine 83
Countries citing papers authored by Harry Heijerman
This map shows the geographic impact of Harry Heijerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Heijerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Heijerman more than expected).
Fields of papers citing papers by Harry Heijerman
This network shows the impact of papers produced by Harry Heijerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Heijerman. The network helps show where Harry Heijerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Harry Heijerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus Hit paper breakdown → | 2000 | 478 |
| 2 | Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis Hit paper breakdown → | 2016 | 424 |
| 3 | Treatment of lung infection in patients with cystic fibrosis: Current and future strategies Hit paper breakdown → | 2012 | 385 |
| 4 | 2005 | 345 | |
| 5 | 2002 | 342 | |
| 6 | 2009 | 205 | |
| 7 | 2014 | 137 | |
| 8 | 1995 | 134 | |
| 9 | 2000 | 112 | |
| 10 | 2005 | 112 | |
| 11 | 1998 | 93 | |
| 12 | 1995 | 90 | |
| 13 | 2002 | 80 | |
| 14 | 2015 | 78 | |
| 15 | 2006 | 78 | |
| 16 | 2004 | 77 | |
| 17 | 2008 | 77 | |
| 18 | 1991 | 74 | |
| 19 | 1997 | 73 | |
| 20 | 2006 | 69 |
About Harry Heijerman
Harry Heijerman is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Pharmacology, Surgery and Pediatrics, Perinatology and Child Health, having authored 145 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (106 papers), Inhalation and Respiratory Drug Delivery (17 papers), Neonatal Respiratory Health Research (17 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Tracheal and airway disorders (13 papers), Pneumonia and Respiratory Infections (12 papers), Antibiotic Resistance in Bacteria (10 papers) and Pharmaceutical studies and practices (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.6k citations), Molecular Medicine (442 citations), Critical Care and Intensive Care Medicine (158 citations), Otorhinolaryngology (126 citations) and Internal Medicine (83 citations). Harry Heijerman has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Daan J. Touw, Gerd Döring, J.S. Elborn, Steven Conway, Henderik W. Frijlink, Elsbeth M. Westerman, Patrick A. Flume, P.P.H. Le Brun, Eitan Kerem and S.P. Conway. Their work appears in journals such as Journal of Cystic Fibrosis, Therapeutic Drug Monitoring, Pediatric Pulmonology, Respiratory Medicine and Journal of Personalized Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.